| scholarly article | Q13442814 |
| P2093 | author name string | Sherrard DJ | |
| Howard GA | |||
| Turner RT | |||
| Baylink DJ | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7738-7740 | |
| P577 | publication date | 1981-08-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 | |
| P478 | volume | 256 |
| Q34534705 | 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation |
| Q28477606 | 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor |
| Q37732575 | 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells |
| Q25257771 | 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. |
| Q58086258 | 25-Hydroxyvitamin D3 metabolism in a human leukemia cell line |
| Q36079391 | Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis |
| Q36515176 | CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders |
| Q34248328 | CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin |
| Q35570010 | Cell sources for bone regeneration: the good, the bad, and the ugly (but promising). |
| Q48323760 | Chronic kidney disease and vitamin D metabolism in human bone marrow-derived MSCs |
| Q37590269 | Cytochrome P450-mediated metabolism of vitamin D. |
| Q72343510 | Do patients who are treated with calcitriol for renal osteodystrophy also need vitamin D3 therapy? |
| Q37607053 | Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination |
| Q37418127 | Effects of 1,25(OH)2 D3 and 25(OH)D3 on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy. |
| Q45257312 | Effects of 24,25(OH)2D3, 1,25(OH)2D3 and 25(OH)D3 on alkaline and tartrate-resistant acid phosphatase activities in fetal rat calvaria |
| Q38552787 | Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase. |
| Q37008974 | Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man. |
| Q70492982 | Extrarenal metabolism of 25-hydroxycholecalciferol in the rat: regulation by 1,25-dihydroxycholecalciferol |
| Q34982729 | FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues |
| Q50347097 | Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D. |
| Q49671351 | Human bone cellsin vitro |
| Q34574684 | Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries |
| Q36990962 | Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3 |
| Q42034057 | In vitro use of vitamin D3 metabolites: culture conditions determine cell uptake |
| Q71824600 | Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix |
| Q43058786 | Metabolic consequences of bilateral nephrectomy |
| Q71043245 | Metabolism of 25-hydroxycholecalciferol by human bone |
| Q37379350 | Murine CD8+ T cells but not macrophages express the vitamin D 1α-hydroxylase |
| Q46550199 | Preferential accumulation in vivo of 24R,25-dihydroxyvitamin D(3) in growth plate cartilage of rats |
| Q35347547 | Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3. |
| Q34323852 | Procalcitonin's amino-terminal cleavage peptide is a bone-cell mitogen |
| Q34535051 | Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes |
| Q68947117 | Stimulation of alkaline phosphatase activity in cultured neonatal mouse calvarial bone cells by parathyroid hormone |
| Q42856370 | Synthesis of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by calvarial cells. Characterization of the enzyme systems |
| Q35377298 | Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function |
| Q35593203 | The effects of 1α, 25-dihydroxyvitamin D3 and transforming growth factor-β3 on bone development in an ex vivo organotypic culture system of embryonic chick femora |
| Q70993472 | The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3 |
| Q68439066 | Vitamin D and parotid gland function in the rat |
| Q26849921 | Vitamin D and the kidney |
| Q37620405 | Vitamin D endocrine system and osteoblasts. |
| Q26824544 | Vitamin D interactions with soy isoflavones on bone after menopause: a review |
| Q24649058 | Vitamin D metabolism and action in human bone marrow stromal cells |
| Q27024504 | Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells |
| Q70396856 | Vitamin D metabolism in pregnant and pseudopregnant rats: identification of 25-hydroxycholecalciferol-1-hydroxylase in decidual tissue |
| Q34536879 | Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts |
| Q34540034 | Vitamin D-endocrine system |
Search more.